The latest update is out from China Resources Pharmaceutical Group Ltd. ( (HK:3320) ).
China Resources Pharmaceutical Group Ltd. has announced a board meeting scheduled for March 26, 2025, to discuss and approve the company’s annual results for the year ending December 31, 2024, and to consider the recommendation of a final dividend. This meeting is significant as it will provide insights into the company’s financial performance and potential returns for shareholders, impacting its market positioning and stakeholder interests.
More about China Resources Pharmaceutical Group Ltd.
China Resources Pharmaceutical Group Ltd. is a company incorporated in Hong Kong, operating in the pharmaceutical industry. It focuses on the production and distribution of pharmaceutical products and services, catering to the healthcare needs of the market.
YTD Price Performance: -9.56%
Average Trading Volume: 1,702
Technical Sentiment Consensus Rating: Sell
Current Market Cap: €3.9B
For an in-depth examination of 3320 stock, go to TipRanks’ Stock Analysis page.